Revenue: The sum of all revenue fields included for a company's operating activities.
Protagonist Therapeutics, Inc. (PTGX) had Revenue of $7.44M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$7.44M |
$-44.38M |
|
-- |
|
$7.44M |
|
$57.79M |
|
$-50.35M |
|
$6.64M |
|
$-43.72M |
|
$-43.72M |
|
$-44.38M |
|
$-44.38M |
|
$-44.38M |
|
$-44.38M |
|
$-50.35M |
|
$-50.97M |
|
63.57M |
|
63.57M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$577.57M |
|
$3.86M |
|
$90.61M |
|
$668.19M |
|
$45.44M |
|
-- |
|
$8.04M |
|
$53.48M |
|
$614.71M |
|
$614.71M |
|
$614.71M |
|
62.58M |
|
| Cash Flow Statement Financials | |
$57.67M |
|
$-49.33M |
|
$22.86M |
|
$97.47M |
|
$128.68M |
|
$31.20M |
|
$45.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-677.09% |
|
-677.09% |
|
-- |
|
-587.84% |
|
-596.80% |
|
$56.08M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
61.46 |
|
1.46 |
|
-7.22% |
|
-7.22% |
|
-6.64% |
|
-7.22% |
|
$9.82 |
|
$0.88 |
|
$0.91 |
|